Since its founding in 1947, Dana-Farber Cancer Institute in Boston, Massachusetts has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research.
Today, the Institute employs more than 13,000 paid and sponsored staff, faculty, and clinicians. Each year, we support over 398,000 outpatient visits, welcome more than 32,000 new patients, and operate over 1,200 active clinical trials. Dana-Farber is internationally renowned for its equal commitment to cutting edge research and provision of excellent patient care. The deep expertise in these two areas uniquely positions Dana-Farber to develop, test, and gain FDA approval for new cancer therapies in its laboratories and clinical settings. Dana-Farber researchers have contributed to the development of 35 of 75 cancer drugs recently approved by the FDA for use in cancer patients.
Dana-Farber Cancer Institute is a principal teaching affiliate of Harvard Medical School, a federally designated Center for AIDS Research, and a founding member of the Harvard Cancer Consortium (formerly called the Dana-Farber/Harvard Cancer Center), a federally designated comprehensive cancer center. Dana-Farber also maintains affiliations with several schools of nursing in the Boston area.
Providing advanced training in cancer treatment and research for an international faculty, the Institute conducts community-based programs in cancer prevention, detection, and control throughout New England, and maintains joint programs with other Boston institutions affiliated with Harvard Medical School and Mass General Brigham, including Brigham and Women's Hospital, Boston Children's Hospital, and Massachusetts General Hospital.
Dana-Farber is supported by the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, and the generous support of numerous foundations and individuals who contribute to the Institute's individual research and clinic programs or to the Jimmy Fund, the principal charity of the Institute, named for one of its child patients.
Dana-Farber Cancer Institute provides expert, compassionate, and equitable care to children, adults, and their families, while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases.